Recently Visited

{{scheme.chgp}}%

Premium

{{ scheme.tag == 'Stock' || scheme.tag == 'News' ? 'View Reco' : 'View Ratings' }}

{{scheme.scoreText}} | Score {{scheme.score}}

Most Searched

{{scheme.chgp}}%

Premium

{{ scheme.tag == 'Stock' || scheme.tag == 'News' ? 'View Reco' : 'View Ratings' }}

{{scheme.scoreText}} | Score {{scheme.score}}

No Matches Found

Ambrx Biopharma, Inc.

What does Ambrx Biopharma, Inc. do?

Ambrx Biopharma, Inc. is a small-cap biotechnology company with a market cap of approximately $1.77 billion. It is currently loss-making, with key metrics indicating a negative P/E ratio, no dividend yield, and a return on equity of -27.29%.

Jun 22 2025 07:25 PM IST

Share Via

{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)

{{ra.stock_return.chgp}}%

{{ra.sensex_return.chgp}}%

Change%

Figures in Rs cr

How big is Ambrx Biopharma, Inc.?

As of Mar 08, Ambrx Biopharma, Inc. has a market capitalization of 1,772.10 million, with recent net sales of 1.14 million and a net loss of 33.13 million over the last two quarters. Shareholder's funds are 117.85 million, and total assets are valued at 154.38 million.

Jun 22 2025 06:34 PM IST

Share Via

${{list.post_title_sep}}$

Share Via

Our weekly and monthly stock recommendations are here

Stock of the Week

Industry

Market Cap

Date of Entry

Entry Price

Target Price

{{sm.target_price }} ({{sm.performance_target }}%)

Holding Duration

Last 1 Year Return

{{sm.performance_1y}}%

Upgrade to Unlock the Latest Stock of the Week

Stock of the Month

{{sm.comp_name}} price as on {{sm.todays_date}}

₹{{sm.price_as_on}} ({{sm.performance}}%)

Industry

Market Cap

Date of Entry

Entry Price

Last 1 Year Return

{{sm.performance_1y}}%

Upgrade to Unlock the Latest Stock of the Month

Ambrx Biopharma, Inc.

How big is Ambrx Biopharma, Inc.?

{{list.post_title}}

{{list.post_title}}